Sartorius (OTCMKTS:SARTF) Short Interest Update

Sartorius (OTCMKTS:SARTF) saw a large decline in short interest in May. As of May 29th, there was short interest totaling 579 shares, a decline of 76.3% from the May 14th total of 2,447 shares. Based on an average daily trading volume, of 53 shares, the short-interest ratio is presently 10.9 days. Approximately 0.0% of the shares of the stock are sold short.

Sartorius Price Performance

SARTF opened at $217.65 on Wednesday. Sartorius has a one year low of $181.58 and a one year high of $227.00. The company has a debt-to-equity ratio of 0.89, a quick ratio of 0.49 and a current ratio of 0.95. The stock’s fifty day moving average is $218.58 and its 200-day moving average is $220.99. The company has a market capitalization of $7.45 billion, a PE ratio of 101.23 and a beta of 0.98.

Sartorius Company Profile

Sartorius AG, trading in the U.S. over the counter under the symbol SARTF, is a Germany-based provider of laboratory and bioprocessing equipment for the pharmaceutical, biotechnology and research industries. The company is organized into two core divisions: Bioprocess Solutions, which focuses on single-use consumables, filtration technologies and upstream and downstream processing systems; and Lab Products & Services, which supplies laboratory instruments, consumables and services, including balances, pipettes, cell counting systems and water purification units.

The Bioprocess Solutions segment serves customers engaged in the development and manufacture of biopharmaceuticals, vaccines and advanced therapies.